Dow Down 0.92% Nasdaq Down 0.83%

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS
14.51 Down 0.23(1.56%) 4:00PM EDT
|After Hours : 14.51 0.00 (0.00%) 4:44PM EDT
Prev Close:14.74
Open:14.72
Bid:14.49 x 3800
Ask:15.25 x 500
1y Target Est:33.63
Beta:3.45
Earnings Date:Nov 6 - Nov 10 (Est.)
Day's Range:14.42 - 14.94
52wk Range:10.76 - 33.33
Volume:1,271,257
Avg Vol (3m):1,905,650
Market Cap:1.30B
P/E (ttm):N/A
EPS (ttm):-1.21
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CLDX

Comparison

Symbol% ChgMkt Cap
CLDXDown 1.56%1.30B
DNDNDown 6.36%160.09M
LLY 0.00%69.32B
RHHBYDown 0.10%247.03B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):505.29
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.32
Quarterly EPS Est (Sep-14) :-0.33
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback